Fourth COVID-19 vaccine dose safe for immunocompromised

A fourth dose of mRNA COVID-19 vaccine seems safe for immunocompromised individuals aged 12 years or older, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...

Diseases, Conditions, Syndromes

Monkeypox: 'This is an entirely new spread of the disease'

One thousand confirmed cases of monkeypox, a disease originating in Africa, have been recorded since early May across at least 30 non-endemic countries such as the United Kingdom, Spain, Portugal, France, the United States, ...


Antibody cocktail offers much-needed COVID-19 protection

In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School of Medicine appears to offer long-lasting protection from COVID-19.

page 1 from 2